New Report Calls For Pushing And Pulling In Global Fight Against Superbugs

A new international report on encouraging R&D for novel antibiotics says that while governments are contributing an estimated $550m annually toward these efforts, an even higher amount of funding is needed. DRIVE-AB's Revitalizing The Antibiotic Pipeline report recommends both "push" incentives like R&D funding and "pull" incentives such as market-entry rewards to companies that bring novel antibiotics to market as ways to address the rising global issue of drug-resistant microbial infections.

Overall, the report – developed over three years by a task force commissioned by the EU's Innovative Medicines Initiative –...